Photo of Kevin Winthrop, M.D., M.P.H.

Kevin Winthrop M.D., M.P.H.

Dr. Winthrop specializes in international ophthalmology, public health and infectious disease epidemiology with an emphasis in mycobacterial diseases and opportunistic infections associated with rheumatic disease and immunosuppressive therapies. He has a special focus in:

Chronic chest infections of all etiology, including mycobacteria The prevention and treatment of infections associated with Biologics and other Immunosuppressive therapies Tuberculosis of the eye (Ophthalmology)

Read more

Education

  • M.D., Oregon Health & Science University, Portland Oregon 1998
  • M.P.H., Univerisity of California at Berkeley, Berkeley California 2003
  • Residency:

    • Stanford University
    • Legacy Emanuel Health Systems, Portland, Oregon
  • Fellowship:

    • National Jewish Medical Center, Denver, Colorado
    • US Centers for Disease Control and Prevention (CDC)

Publications

  • "Infections and Rheumatoid Arthritis"   2009
  • "Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA" Emerging Infectious Diseases March 2011
  • "Implications for biologic therapy" JAMA Dermatology August 2013
  • "Reply to Wallis from Winthrop et al." Clinical Infectious Diseases December 15 2008
  • "Mycobacterium chelonae facial infections following injection of dermal filler" Aesthetic Surgery Journal February 2013
  • "Angiosarcoma of the eyelid with superimposed enterobacter infection" Ophthalmic Plastic and Reconstructive Surgery August 5 2014
  • "Therapy" Nature Reviews Rheumatology December 2011
  • "Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy" Arthritis and Rheumatology May 1 2015
  • "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs" Annals of the Rheumatic Diseases June 2010
  • "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis." Arthritis and Rheumatology May 2012
  • "Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001" Emerging Infectious Diseases October 1 2002
  • "Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection" Arthritis Research and Therapy May 22 2015
  • "OdporúÄ�ania EULAR pre manažment reumatoidnej artritídy syntetickými a biologickými ochorenie modifikujúcimi antireumatickými liekmi" Rheumatologia  2014
  • "Happy buddha?" Clinical Infectious Diseases June 1 2012
  • "Review and update on the epidemiology, clinical presentation, diagnosis, and treatment of fungal Keratitis" Current Fungal Infection Reports December 2013
  • "Association between anti-TNF-α therapy and interstitial lung disease" Pharmacoepidemiology and Drug Safety April 2013
  • "Update on the safety profile of certolizumab pegol in rheumatoid arthritis" Annals of the Rheumatic Diseases January 1 2015
  • "Safety of synthetic and biological DMARDs" Annals of the Rheumatic Diseases March 1 2014
  • "Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort." Retina February 2009
  • "Atrophic fundus lesions associated with untreated retinopathy of prematurity" American Journal of Ophthalmology  1997
  • "Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target" Annals of the Rheumatic Diseases January 2014
  • "A systematic literature review of drug therapies for the treatment of psoriatic arthritis" Annals of the Rheumatic Diseases March 2012
  • "Photo Quiz. Happy buddha?" Clinical Infectious Diseases June 2012
  • "Effects of the federal antitrust law on horizontal mergers of single specialty medical practices" Ophthalmology Clinics of North America  1997
  • "Interferon-γ release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients" Clinical Journal of the American Society of Nephrology September 2008
  • "Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists" Ocular Immunology and Inflammation February 1 2015
  • "Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis" Arthritis and Rheumatology October 1 2014
  • "Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases" Arthritis and Rheumatology April 2012
  • "Infections and biologic therapy for rheumatoid arthritis"  June 19 2014
  • "Ocular toxoplasmosis II" Clinical and Experimental Ophthalmology January 2013

Additional information

Edit profile